(+)-dexrazoxane multiple interactions ISO RGD:1622287 6480464 [Doxorubicin co-treated with Dexrazoxane] results in increased expression of BRP44 mRNA CTD PMID:26873546 (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MPC2 mRNA] CTD PMID:31150632 1,2-dimethylhydrazine decreases expression ISO RGD:1622287 6480464 1, 2-Dimethylhydrazine results in decreased expression of BRP44 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1622287 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MPC2 mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO RGD:1622287 6480464 Estradiol results in decreased expression of MPC2 mRNA CTD PMID:19484750 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1604029 6480464 Dihydrotestosterone results in increased expression of BRP44 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MPC2 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1622287 6480464 Tetrachlorodibenzodioxin results in decreased expression of MPC2 mRNA CTD PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1622287 6480464 Tetrachlorodibenzodioxin affects the expression of MPC2 mRNA CTD PMID:21570461 2-hydroxypropanoic acid increases expression ISO RGD:1604029 6480464 Lactic Acid results in increased expression of MPC2 mRNA CTD PMID:30851411 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:1622287 6480464 3 more ... CTD PMID:19467301 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1622287 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of MPC2 mRNA CTD PMID:24848799 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of MPC2 mRNA CTD PMID:36041667 5-fluorouracil affects response to substance ISO RGD:1604029 6480464 MPC2 protein affects the susceptibility to Fluorouracil CTD PMID:16217747 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of MPC2 mRNA CTD PMID:31881176 aflatoxin B1 decreases expression ISO RGD:1604029 6480464 Aflatoxin B1 results in decreased expression of MPC2 mRNA CTD PMID:21641981 , PMID:22100608 aflatoxin B1 decreases methylation ISO RGD:1604029 6480464 Aflatoxin B1 results in decreased methylation of MPC2 gene CTD PMID:27153756 antirheumatic drug increases expression ISO RGD:1604029 6480464 Antirheumatic Agents results in increased expression of MPC2 mRNA CTD PMID:24449571 benzo[a]pyrene decreases expression ISO RGD:1622287 6480464 Benzo(a)pyrene results in decreased expression of MPC2 mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression ISO RGD:1604029 6480464 Benzo(a)pyrene results in decreased expression of MPC2 mRNA CTD PMID:32234424 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MPC2 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of MPC2 mRNA CTD PMID:36041667 bisphenol A increases expression ISO RGD:1622287 6480464 bisphenol A results in increased expression of MPC2 mRNA CTD PMID:33221593 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MPC2 mRNA CTD PMID:30903817 bisphenol A affects expression ISO RGD:1604029 6480464 bisphenol A affects the expression of MPC2 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:1604029 6480464 bisphenol A results in decreased expression of MPC2 mRNA, bisphenol A results in decreased expression of MPC2 protein CTD PMID:29275510 , PMID:34186270 Bisphenol B increases expression ISO RGD:1604029 6480464 bisphenol B results in increased expression of MPC2 protein CTD PMID:34186270 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of MPC2 mRNA CTD PMID:36041667 choline multiple interactions ISO RGD:1622287 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MPC2 gene CTD PMID:20938992 cisplatin increases expression ISO RGD:1604029 6480464 Cisplatin results in increased expression of MPC2 mRNA CTD PMID:27594783 clobetasol increases expression ISO RGD:1622287 6480464 Clobetasol results in increased expression of MPC2 mRNA CTD PMID:27462272 clofibrate multiple interactions ISO RGD:1622287 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of MPC2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MPC2 mRNA] CTD PMID:17585979 cocaine increases expression EXP 6480464 Cocaine results in increased expression of MPC2 protein CTD PMID:25100957 copper(II) sulfate decreases expression ISO RGD:1604029 6480464 Copper Sulfate results in decreased expression of MPC2 mRNA CTD PMID:19549813 cyclophosphamide affects response to substance ISO RGD:1604029 6480464 MPC2 protein affects the susceptibility to Cyclophosphamide CTD PMID:16217747 cyclosporin A decreases expression ISO RGD:1604029 6480464 Cyclosporine results in decreased expression of MPC2 mRNA CTD PMID:20106945 , PMID:25562108 dexamethasone multiple interactions ISO RGD:1622287 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of MPC2 mRNA CTD PMID:24848799 diethylstilbestrol decreases expression ISO RGD:1604029 6480464 Diethylstilbestrol results in decreased expression of MPC2 mRNA CTD PMID:36621641 dorsomorphin multiple interactions ISO RGD:1604029 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MPC2 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1622287 6480464 Doxorubicin results in decreased expression of BRP44 mRNA CTD PMID:26873546 doxorubicin increases expression ISO RGD:1604029 6480464 Doxorubicin results in increased expression of MPC2 mRNA CTD PMID:29803840 doxorubicin multiple interactions ISO RGD:1622287 6480464 [Doxorubicin co-treated with Dexrazoxane] results in increased expression of BRP44 mRNA CTD PMID:26873546 enzalutamide decreases expression ISO RGD:1604029 6480464 enzalutamide results in decreased expression of BRP44 mRNA CTD PMID:29581250 fenthion increases expression ISO RGD:1622287 6480464 Fenthion results in increased expression of MPC2 mRNA CTD PMID:34813904 folic acid multiple interactions ISO RGD:1622287 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of MPC2 mRNA CTD PMID:22061828 hydrogen peroxide affects expression ISO RGD:1604029 6480464 Hydrogen Peroxide affects the expression of MPC2 mRNA CTD PMID:20044591 isotretinoin decreases expression ISO RGD:1604029 6480464 Isotretinoin results in decreased expression of MPC2 mRNA CTD PMID:20436886 ivermectin decreases expression ISO RGD:1604029 6480464 Ivermectin results in decreased expression of MPC2 protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:1622287 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MPC2 gene CTD PMID:20938992 lead(0) affects expression ISO RGD:1604029 6480464 Lead affects the expression of BRP44 mRNA CTD PMID:28903495 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of MPC2 mRNA CTD PMID:24136188 menadione affects expression ISO RGD:1604029 6480464 Vitamin K 3 affects the expression of MPC2 mRNA CTD PMID:20044591 methidathion increases expression ISO RGD:1622287 6480464 methidathion results in increased expression of MPC2 mRNA CTD PMID:34813904 methyl methanesulfonate increases expression ISO RGD:1604029 6480464 Methyl Methanesulfonate results in increased expression of MPC2 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1604029 6480464 methylmercuric chloride results in decreased expression of MPC2 mRNA CTD PMID:28001369 mitoxantrone affects response to substance ISO RGD:1604029 6480464 MPC2 protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of MPC2 mRNA CTD PMID:24136188 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of MPC2 mRNA CTD PMID:24136188 p-menthan-3-ol multiple interactions EXP 6480464 [Tobacco Smoke Pollution co-treated with Menthol] results in increased expression of MPC2 protein CTD PMID:27818348 paracetamol multiple interactions ISO RGD:1622287 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of MPC2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MPC2 mRNA] CTD PMID:17585979 paracetamol decreases expression ISO RGD:1604029 6480464 Acetaminophen results in decreased expression of MPC2 mRNA CTD PMID:25704631 , PMID:29067470 paracetamol affects expression ISO RGD:1622287 6480464 Acetaminophen affects the expression of MPC2 mRNA CTD PMID:17562736 parathion increases expression ISO RGD:1622287 6480464 Parathion results in increased expression of MPC2 mRNA CTD PMID:34813904 phenylmercury acetate increases expression ISO RGD:1604029 6480464 Phenylmercuric Acetate results in increased expression of MPC2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1604029 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MPC2 mRNA CTD PMID:27188386 quercetin decreases expression ISO RGD:1604029 6480464 Quercetin results in decreased expression of MPC2 mRNA CTD PMID:21632981 rac-lactic acid increases expression ISO RGD:1604029 6480464 Lactic Acid results in increased expression of MPC2 mRNA CTD PMID:30851411 SB 431542 multiple interactions ISO RGD:1604029 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MPC2 mRNA CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1604029 6480464 Silicon Dioxide analog results in decreased expression of BRP44 mRNA CTD PMID:25895662 sunitinib decreases expression ISO RGD:1604029 6480464 Sunitinib results in decreased expression of MPC2 mRNA CTD PMID:31533062 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of MPC2 mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:1622287 6480464 Carbon Tetrachloride results in decreased expression of MPC2 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MPC2 mRNA] CTD PMID:31150632 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of MPC2 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:1622287 6480464 titanium dioxide results in decreased expression of MPC2 mRNA CTD PMID:23557971 tributylstannane increases expression ISO RGD:1622287 6480464 tributyltin results in increased expression of MPC2 mRNA CTD PMID:24848799 triptonide increases expression ISO RGD:1622287 6480464 triptonide results in increased expression of MPC2 mRNA CTD PMID:33045310 tungsten increases expression ISO RGD:1622287 6480464 Tungsten results in increased expression of MPC2 mRNA CTD PMID:30912803 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of MPC2 mRNA CTD PMID:24136188 valproic acid decreases methylation ISO RGD:1604029 6480464 Valproic Acid results in decreased methylation of MPC2 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1604029 6480464 Valproic Acid results in increased expression of MPC2 mRNA CTD PMID:23179753 , PMID:27188386 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of MPC2 mRNA CTD PMID:23555832 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of MPC2 mRNA CTD PMID:23034163 zoledronic acid decreases expression ISO RGD:1604029 6480464 zoledronic acid results in decreased expression of MPC2 mRNA CTD PMID:24714768